Secondary Outcome Measures :
Maybe considering the trial started dec 2018 and first enrolment Feb 2019. Aug would spot on for 18 week or even 24 week metrics.
- CBR [ Time Frame: 18 and 24 weeks ]
rate of patients with clinical benefit at 18 and 24 weeks- https://clinicaltrials.gov/ct2/show/NCT03765983
Watch this spot for sure as it was highlighted in the Kazia June newsletters of coming dates
- Forums
- ASX - By Stock
- KZA
- SNO August Brain Mets Conf
SNO August Brain Mets Conf, page-3
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online